Claim Missing Document
Check
Articles

STUDI PENDAHULUAN NONTUBERCULOUS MYCOBACTERIA (NTM): PEMBENTUKAN BIOFILM, MOTILITAS GESER, DAN POLA KEPEKAAN ANTIBIOTIK Titik Nuryastuti; Ning Rintiswati; Praseno Praseno
Mandala Of Health Vol 11 No 1 (2018): Mandala Of Health
Publisher : Fakultas Kedokteran Universitas Jenderal Soedirman

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (369.205 KB) | DOI: 10.20884/1.mandala.2018.11.1.570

Abstract

Nontuberculous mycobacteria (NTM) adalah mikrorganisme yang banyak dijumpai di lingkungan, namun, baru-baru ini dianggap patogen karena kejadian infeksinya meningkat secara signifikan. Penelitian ini bertujuan untuk mengetahui kemampuan pembentukan biofilm isolat NTM, korelasinya dengan sifat motilitas geser, dan untuk menganalisis pola kepekaan antibiotik. Strain NTM yang dipakai dalam penelitian ini adalah 10 isolat klinis NTM yang diperoleh dari laboratorium TB, Departemen Mikrobiologi, Fakultas Kedokteran UGM Yogyakarta. Kemampuan pembentukan biofilm dideteksi dengan menggunakan uji mikrotiter dan pewarnaan dengan kristal violet 1%. Uji motilitas geser dilakukan pada medium motilitas, terdiri dari 0,3% Middlebrook 7H9-agar tanpa suplemen. Pola kepekaan antibiotik diteliti dengan teknik dilusi sesuai metode CLSI. Dari penelitian ini menunjukkan bahwa 7 dari 10 isolat NTM merupakan penghasil biofilm kuat, sementara 1 isolat sebagai strain penghasil biofilm moderat, dan 2 isolat tidak menghasilkan biofilm. Sementara itu, strain pembentuk biofilm mampu melakukan motilitas geser pada agar semisolid, dan 2 isolat NTM yang tidak memiliki kemampuan pembentukan biofilm tidak dapat melakukan motilitas geser. Sifat pembentukan biofilm berkorelasi dengan kemampuan isolat NTM untuk melakukan motilitas geser pada media agar semisolid. Klaritromisin merupakan antibiotik yang paling efektif terhadap isolat NTM yang diuji (poten terhadap 50% isolat uji), diikuti oleh gentamisin (40%), sedangkan kanamisin, levofloxacin, dan ofloxacin menunjukkan tingkat potensi yang sama (30%). Ceftriaxone hanya mampu menghambat pertumbuhan isolat NTM sekitar 20%. Selanjutnya, kotrimoksazol dan amoksisilin memiliki aktivitas in vitro yang buruk terhadap isolat NTM karena tidak ada isolat NTM yang sensitif terhadap kedua antibiotik ini. Nontuberculous mycobacteria (NTM) are ubiquitous organisms commonly found in the environment. However, recently it is considered as emerging global interest since the incidence increase significantly. This study aimed to investigate the biofilm forming ability of NTM isolates, correlated with the sliding motility properties, and to analyze their antibiotic susceptibility pattern. NTM strain included in this study were 10 NTM clinical isolates obtained from TB laboratory, Microbiology Departement, Faculty of Medicine UGM Yogyakarta. Biofilm forming capability was detected by using biofilm development assay in microtiter plate and staining with 1% crystal violet. Sliding motility assay was performed on motility medium, consisting of Middlebrook 7H9- 0.3% agar without supplements. Antibiotic susceptibility pattern was investigated by macrobroth dilution technique according to CLSI methods. Our study revealed that 7 out of 10 NTM isolates produced biofilm strongly, while 1 isolate demontrated as moderate biofilm former strain, and the remaining 2 isolates did not produce biofilm on polysterene substrate. Meanwhile, biofilm-former strain are able to slide on semisolid agar, and 2 non-adherent NTM isolates did not have ability to perform sliding motility. A good correlation was found between mycobacterial sliding and biofilm assembly of NTM isolates. Clarithromycin has been shown as the most effective antibiotic against NTM isolates tested, which was active against 50% of all isolates, followed by gentamycin (40%), while kanamycin, levofloxacin, and ofloxacin showed the same level of potency (30%). Ceftriaxone was only able to inhibit the growth of NTM isolates about 20%. Furthermore, cotrimoxazole and amoxicillin had poor in vitro activity against NTM species.
Evaluation the Rationality of Clinical Outcomes of Antibiotic Use and Patterns of Bacterial Resistance to Antibiotics in Children with Pneumonia Cindy Elvionita; Ika Puspita Sari; Titik Nuryastuti
Majalah Farmaseutik Vol 19, No 1 (2023)
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/farmaseutik.v19i1.76103

Abstract

Pneumonia is a respiratory infection that attacks the lungs in the lung parenchyma tissue or alveoli. Pneumonia is one of the leading causes of death in children worldwide. Rational use of antibiotics can reduce the risk of antibiotic resistance. This study used observational analytics with a retrospective cohort design. The research subjects were pediatric patients with a diagnosis of pneumonia who were hospitalized at Dr. Sardjito Yogyakarta period 1 January – 31 December 2020. The rationality of the use of antibiotics was evaluated using the Gyssens method. The clinical outcome observed was the patient's condition improving or not improving after 3 to 5 days of antibiotic administration. Chi-Square test to see the relationship of antibiotic rationality to clinical outcomes and multiple logistic regression analysis to analyze the relationship of confounding variables to clinical outcomes. From 141 patients, 211 antibiotic regimens were obtained, with details of 186 empiric antibiotics and 25 definitive antibiotics. The rational use of antibiotics in empirical and definitive antibiotics was 140 regimens (75.27%) and 22 regimens (88%). Total irrational antibiotics (category I-VI) from empirical and definitive antibiotics were 24.73% and 12%, respectively. There is a significant relationship between the rationality of antibiotics with clinical outcomes both empirical and definitive antibiotics (p<0.05). Meanwhile, for confounding variables, there was no significant relationship to the clinical outcome (p>0.05). The most common bacteria were Klebsiella pneumoniae and Acinetobacter baumanii. Klebsiella pneumoniae was the most resistant to ampicillin, ampicillin sulbactam and ceftriaxone antibiotics and Acinetobacter baumanii was the most resistant ampicillin.
Treatment of the cytokine storm in COVID-19: review of clinical pharmacology Aisyah Nur Sapriati; Fita Rahmawati; Titik Nuryastuti
Jurnal Sains Farmasi & Klinis Vol 10, No 2 (2023): J Sains Farm Klin 10(2), Agustus 2023
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.10.2.162-183.2023

Abstract

The cause of the COVID-19 pandemic can be attributed to the Acute Respiratory Syndrome Virus-2 (SARS-CoV-2). COVID-19 manifests with severe symptoms in the upper respiratory tract and can progress to a critical condition due to an acute hyperinflammatory response that triggers a cytokine storm. The cytokine storm refers to an excessive or impaired production of proinflammatory cytokines, resulting in immune dysregulation and uncontrolled inflammatory activity. To effectively address the hyperinflammatory state induced by SARS-CoV-2 infection, it is imperative to explore promising strategies aimed at overcoming the cytokine storm, such as the prompt initiation of anti-inflammatory therapy. Several classes of drugs can potentially prevent the deterioration of COVID-19 patients by mitigating immune system dysregulation and suppressing uncontrolled inflammatory responses. These drug classes encompass corticosteroids, chloroquine and hydroxychloroquine, inhibitors of interleukin-1 (IL-1), inhibitors of interleukin-6 (IL-6), inhibitors of tumor necrosis factor (TNF), and anti-inflammatory drugs. Additionally, tumor necrosis factor alpha (TNF-α) inhibitors, as well as inhibitors targeting the Janus kinase signaling pathway and activator of transcription (JAK/STAT), have exhibited efficacy in treating COVID-19. This efficacy is evident when considering the drug's mechanism of action and pharmacokinetics, while also taking into account the tolerable side effects associated with their usage
Urinary Tract Infection (UTI) caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae: a case series Qonita Imma Irfani; Dessy Kurnia Sari; Dewi Purbaningsih; Tri Wibawa; Titik Nuryastuti
Journal of Clinical Microbiology and Infectious Diseases Vol. 1 No. 1 (2021): Available Online: June 2021
Publisher : Indonesian Society for Clinical Microbiology (Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jcmid.v1i1.2

Abstract

Introduction: A urinary tract infection (UTI) is an infection in any part of the urinary system, occurring in the kidneys, bladder, ureters, and urethra. UTI incidence in Indonesia was high enough. The prevalence of UTI in the community enhances in line with the increase of age. 40-60 years had a prevalence rate of 3.2%, while at the age of  ≥65, a UTI had a prevalence rate of 20%. UTIs are among the most common infections in humans. Enterobacteria that produce extended-spectrum beta-lactamase (ESBL) is one of the most frequent causes. Prevalence of the ESBL bacterial infection is developing due to the widespread prescription of antibiotics around the world. Thus, our articles established several UTI cases of various ages and their antibiotic susceptibility. Case Description: This case report series presents eight cases describing a UTI caused by Enterobacteriaceae producing ESBL in various ages. Data were collected retrospectively from secondary sources of laboratory results. Patient baby-child mostly had a history of sepsis. Other than that patient had hydronephrosis kidney, seizure, fever. On the other hand, the patient's old man and woman had a history of fever, shock spinal and fracture, malignancy. All patients were tested for antibiotic susceptibility and mostly still sensitive with amikacin, meropenem, nitrofurantoin, and fosfomycin. Conclusions: Our case series established that patients with UTI were mainly still sensitive to amikacin, meropenem, nitrofurantoin, and fosfomycin. We should implement and maintain contact precautions throughout the hospital wards to prevent the transmission of ESBL infections.
Identification of Streptococcus intermedius and Stenotrophomonas maltophilia in recurrent leucorrhoea: a case report Marselinus Edwin Widyanto Daniwijaya; Atthobari; Ade Christanti Putri Sidabutar; Devi Artami Susetiati; Titik Nuryastuti
Journal of Clinical Microbiology and Infectious Diseases Vol. 1 No. 2 (2021): Available Online: December 2021
Publisher : Indonesian Society for Clinical Microbiology (Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jcmid.v1i2.9

Abstract

Introduction: Leucorrhoea or fluor albus a whitish vaginal discharge is commonly found in reproductive women with familiar symptoms such as itching, with or without distinctive odor. Several factors are responsible for leucorrhoea including infectious and non-infectious factors. Streptococcus intermedius and Stenotrophomonas maltophilia are bacteria that cause infections that are rarely found in vaginal discharge. Case description: A 23-year-old woman, with a history of recurrent vaginal discharge, presented herself in the outpatient clinic dermatology and venereology RSUP Dr. Sardjito, with the main complaint of vaginal discharge. On the previous visit to the outpatient clinic, she was diagnosed with vulvovaginal candidiasis and received Azithromycin, ketoconazole.  Microbiology culture of the vaginal swab results in two bacterial infections Streptococcus intermedius and Stenotrophomonas maltophilia. Conclusion: A rare finding on the identification of Streptococcus intermedius and Stenotrophomonas maltophilia in outpatients with recurrent leucorrhoea. These findings suggest that Streptococcus intermedius and Stenotrophomonas maltophilia which is an uncommon profile of microorganism could also be assumed to be involved in recurrent leucorrhoea in this case report. Other pathogenic organisms should be considered since there limitation in the identification process in diagnostic of the patient.
Streptococcus agalactiae is resistant to β-lactam antibiotics in a diabetic patient with foot infection: a case report Yolanda Pitra Kusumadewi; Afdina Melya Ganes Febiyanti; Ilma Tazkiya; Galang Ridha Allatief; Annisa Somaningtyas; Cicilia Widhi Astuti; Ika Puspitasari; Kuwat Triyana; Tri Wibawa; Titik Nuryastuti
Journal of Clinical Microbiology and Infectious Diseases Vol. 2 No. 1 (2022): Availabel Online: June 2022
Publisher : Indonesian Society for Clinical Microbiology (Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/jcmid.v2i1.13

Abstract

Introduction: Diabetic foot infection is a complication that often occurs in people with diabetes mellitus. Staphylococcus aureus is the most common microorganism found in diabetic foot infections. In addition, coagulase-negative staphylococci, Enterococcus faecalis, Streptococcus agalactiae, and Pseudomonas aeruginosa can also be demonstrated. Diabetic foot infection treatment usually takes a long time which may increasing the risk of antibiotic resistance. This article will present a unique and interesting case about Streptococcus agalactiae resistant to β-lactam infection. Case description: A 56-year-old man presented with a long history of diabetes mellitus but had not taken anti-diabetic drugs and had no history of previous use of antibiotics. Since 2016 his right foot had a recurring wound that he routinely treated. Microbiology culture of the wound swab obtained three bacteria namely Streptococcus agalactiae, Proteus mirabilis and Klebsiella pneumoniae which is resistant to β-lactam antibiotics. Conclusion: The identification of Group B Streptococcus bacteria (Streptococcus agalactiae) which are resistant to β-lactam antibiotics (penicillin, third and fourth generation cephalosporins) which were found in this case, reminds all medical personnel to be more careful and prudent in the rational use of antibiotics.
The Use of an Ambroxol Solution to Assess Acute Dermal Irritation on Rabbit Skin Munifah Wahyuddin; Mukhriani; Vera Olfiana; Ika Puspita Sari; Rizka Humardewayanti Asdie; Titik Nuryastuti
Ad-Dawaa: Journal of Pharmaceutical Sciences Vol 5 No 2 (2022)
Publisher : Universitas Islam Negeri Alauddin Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24252/djps.v6i1.38401

Abstract

Ambroxol can overcome infections due to the presence of biofilms in the body by interfering with the formation of sticky biofilms and reducing biofilm production, so it has the potential to be used in topical preparations for the treatment of infections. This study aimed to measure the irritating effect on the skin of rabbits resulting from the ambroxol solution to assess the safety of the ambroxol solution. The methods refers to BPOM 2020, namely by dabbing 0.5 ml of ambroxol solution on the back skin of rabbits, then covering it with gauze and non-irritant plasters, after 4 hours of cleaning of residues is then observed at 1 , 24, 48 and 72 hours to see whether or not there was an effect of erythema and edema arising from the influence of the experiment, and at the end of the investigation, a histopathological test was carried out. The results of the research are Macroscopically the ambroxol solution did not show any erythema and edema, so the primary irritation index score was obtained for all test solutions with a score of 0. In contrast, in the microscopic irritation test, the score for erythema was 4 and for edema was 3. . From this research, it can be concluded that the ambroxol solution non-irritating to the skin. KEYWORDS: Biofilm, ambroxol solutions, acute irritation test.
Streptococcus agalactiae caused a Secondary Infection in Sexually Transmitted Infections : Case Report Nurpagino, Bombong; Apriyanto, Muchammad; Susetiati, Devi Artami; Nuryastuti, Titik
Ahmad Dahlan Medical Journal Vol. 5 No. 1 (2024): May 2024
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Streptococcus agalactiae is a gram-positive coccus bacterium that is rarely reported to cause genital infections in males. This study discusses case of a young man with lesions on the genital as a secondary infection caused by Streprococcus agalactiae. A 25-year-old man came to the dermatology and venereology clinic of Dr. Sardjito General Hospital, complaining of a wound on the penis that had not healed in the last 3 months ago, The patient has a history of having sex with men without using a condom and frequently changing partners. The patient was known to be infected with HIV (Human Immunodeficiency Virus) and the results of the IgG HSV-2 (Herpes Simplex Virus-2) serological examination were positive. The results of microbiological examination of the wound bed swab sample showed the growth of Streptococcus agalactiae. Previously the patient received antiretroviral therapy, clindamycin oral, and erythromycin cream. The wound on the penis got better, but before the wound completely recovered, the patient did not visit anymore. Streptococcus agalactiae secondary infection in cases of sexually transmitted infections is a rare case. In this case, the finding of Streptococcus agalactiae can be considered as a pathogen. In cases of sexually transmitted infections with sores on the genital, a microbiological examination is recommended to determine the causative microorganism, and an antibiotic sensitivity test to determine the therapy.  
Trend Antimicrobial Resistance Patterns in Patients with Septic at The Intensive Care Unit : A Five years Retrospective Study Nurkhalika, Rachmi; Sari, Ika Puspita; Nuryastuti, Titik
Majalah Farmaseutik Vol 19, No 4 (2023)
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/farmaseutik.v19i4.76105

Abstract

Sepsis is a potentially fatal medical condition characterized by decreased organ function, lower mortality, and increased resistance. Antibiotic resistance can develop as a result of overuse and inappropriate indications. The WHO AWaRe classification categorizes antibiotics based on their potency and potential impact on antimicrobial multidrug resistance (AMR). This classification will make it easier to organize and select antibiotics, as well as reduce the occurrence of resistance. The goal of this study was to identify the pattern of bacterial resistance to antibiotics in septic patients from 2017-2021, as categorized by the WHO AWaRe classification. This study used a descriptive, non-experimental design and was carried out at the UGM Academic Hospital. The information was collected retrospectively from the medical records of patients diagnosed with sepsis in the intensive care unit and treated between January 2017-December 2021, who fulfilled the inclusion and exclusion criteria. According to the resistance pattern between 2017-2021, the gram-negative bacteria that caused sepsis were 55 isolates. The most common bacteria causing sepsis were Pseudomonas aeruginosa and Acinetobacter baumannii. When compared to antibiotics in the reserve category (meropenem and vancomycin), antibiotics in the access category (penicillin and/or beta-lactam inhibitors and first-generation cephalosporins), experienced the most resistance.
Gambaran Terapi dan Luaran Klinik Bedaquiline Pada Pasien MDR TB di RSUP Dr Kariadi Semarang Puspitasari, Niken; Puspitasari, Ika; Nuryastuti, Titik
Majalah Farmaseutik Vol 20, No 1 (2024)
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/farmaseutik.v20i1.77632

Abstract

Tuberkulosis (TB) merupakan penyakit infeksi penyebab kematian terbanyak di dunia. Bedaquiline adalah antimikroba baru yang mempunyai aktivitas spesifik melawan Mycobacterium tuberculosis. Tujuan penelitian ini untuk mengetahui gambaran terapi dan luaran klinik Bedaquiline pada pasien MDR TB di RSUP Dr Kariadi Semarang. Subyek penelitian yaitu pasien MDR TB di RSUP Dr. Kariadi Semarang periode 1 Januari 2017 sampai dengan 31 Juli 2021. Analisis data dilakukan secara deskriptif menggunakan metode univariat meliputi data karakteristik subyek, gambaran penggunaan obat, luaran klinik pasien. Terdapat 125 pasien MDR TB yang memenuhi kriteria inklusi dan eksklusi. Rata-rata usia pasien 46,6 tahun ± 13,1 tahun; 57,6% merupakan laki-laki; 53,6% berpendidikan SMA; 67,2% pasien mempunyai pekerjaan; 8,2% pasien berstatus menikah; dan 88,0% pasien mempunyai IMT normal. Jenis obat tuberkulosis yang paling banyak digunakan bersamaan dalam regimen mengandung Bedaquiline yaitu Clofazimin (87,2%), Cycloserin dan Ethambutol (82,4%), Pyrazinamid (80,8%), Isoniazid (69,6%), Ethionamid (65,6%), Levofloxacin (64,8%) dan Linezolid (48,8%). Pasien mengalami konversi kultur sputum rata-rata 52,2 hari dengan SD 42 hari. Tingkat keberhasilan terapi mencapai 74,4% (pasien sembuh 73,6% dan pengobatan lengkap 0,8%). Pasien yang meninggal dunia sebanyak 18 pasien (14,4%); putus berobat 8 pasien (6,4%); dan gagal pengobatan 6 pasien (4,8%).
Co-Authors . Mursiti Abu Tholib Aman Ade Christanti Putri Sidabutar Afdina Melya Ganes Febiyanti Aisyah Nur Sapriati Altaufik Ngani Amaia, Devika N. Amalia Setyati Aman, Alia Hanifa Aminy, Sayyidah A. Andi Ameilia Sari Riandika Anggraeni, Nuniek Annisa Aulia Savitri Annisa Somaningtyas Anton Pratama Apriyanto, Muchammad Arief Nurrochmad As, Musdalifa Atikana, Akhirta Atthobari Avanilla Fany Septyasari Bastiaan P. Krom, Bastiaan Bastian P. Krom Cicilia Widhi Astuti Cindy Elvionita Daru Estiningsih Dessy Kurnia Sari Devi Artami Susetiati Dewi Purbaningsih Dhannia Fitratiara Diah Susanti Diyan Ajeng Rossetyowati Diyan Ajeng Rossetyowati Djoko Wahyono Djoko Wahyono Dwi Utami Anjarwati Dwikisworo Setyowireni Edwin W. Daniwijaya Eggi Arguni Elya Antariksana Bachmida Emi Rusdiyati Endang Estriningsih Ervina Damayanti Estiningsih, Daru Estriningsih, Endang Firdhani Satia Primasari Fita Rahmawati Fita Rahmawati Galang Ridha Allatief Hakim, Mohamad Saifudin Hamzah, Hasyrul Hananun Zharfa Hanifah Handi Virawan Hardyanto Soebono Henk J. Busscher Henk J. Busscher, Henk J. Henny C. van der Mei Henny C. van der Mei, Henny C. Hera Nirwati Ika Puspita Sari Ika Puspita Sari Ika Puspita Sari Ika Puspita Sari IKA PUSPITA SARI Ika Puspita Sari Ika Puspita Sari Ika Puspitasari Ika Puspitasari Ika Puspitasari Ika Puspitasari Ilma Tazkiya Iman Iman Ishak SKM., MPH IWAN DWIPRAHASTO Kholidah, Siti Nurhayati Kris Kurniawan Kuwat Triyana LINDA SUKMARINI Linda, Vitia Ajeng Nur Lucky Herawati Luthvia Annisa Marselinus Edwin Widyanto Daniwijaya Maulidia, Faiqoh Nur Maulidiah, Rizka Mawarti, Yuli Meilia Nhadia Amalia Mubasysyir Hasanbasri Mujahidah, Mujahidah Mukhriani, Mukhriani Munifah Wahyuddin Mursiti, Mustofa, Handry Darussalam, Titik Nuryastuti, Mursiti, Mustofa Mustofa Nanang Munif Yasin Ni Luh Putu Vidya Paramita Niken Puspitasari Ning Rintiswati Nunung Yuniarti Nunung Yuniarti Nurkhalika, Rachmi Nurpagino, Bombong Prameshwara, Almarissa Ajeng Praseno Praseno Pratama, Anton Prawarni, Vidyadhari Puspa Prayoga, Muhammad Bagas Pujilestari, Dwi PUSPITA LISDIYANTI Qonita Imma Irfani Rachma Dewi Isnaini Putri Rahmawati, Fita Rakhmat Ari Wibowo Rebriarina Hapsari Retno Wahyuningrum Rina Triasih Ritmaleni, Ritmaleni Rizal Fauzi Rizka Humardewayanti Asdie Rizka Humardewayanti Asdie Rizqi Nurul Khasanah Roel Kuijer Roel Kuijer, Roel SAMUEL BUDI Sapriati, Aisyah Nur Setiawati, Setiawati SHANTI RATNAKOMALA Subagus Wahyuono Supriyati Susi Iravati Sylvia Utami Tunjung Pratiwi Takushi Kaneko Tatang Irianti Tina Amnah Ningsih Titi Ira Pangestuti Tri Murti Andayani Tri Murti Andayani Tri Wibawa Triana Hertiani Tristina Devi Azzahra Untari, Febriana Vera Olfiana Wahyuddin, Munifah Wihda Yanuar Wihda Yanuar Yanuar, Wihda Yeli Trimayanti Yolanda Pitra Kusumadewi Yusrizal Djam’an Saleh ZULLIES IKAWATI